Delivery Order SPE2DB22D3004-SPE2DB25FND99

Award Date 10/9/24
Potential Completion Date 10/10/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FND99
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $5,291.30, is for the delivery of 4,566,065,391 units of valganciclovir 450 mg tablets over a two-year period ending in October 2024. The contract is structured as a fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a comprehensive range of medical commodities and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation for pharmaceutical products and medical supplies.

Generated 1/8/25, 9:13 AM